Aquestive Therapeutics (AQST) Assets Average: 2018-2025
Historic Assets Average for Aquestive Therapeutics (AQST) over the last 7 years, with Sep 2025 value amounting to $128.6 million.
- Aquestive Therapeutics' Assets Average rose 13.05% to $128.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.6 million, marking a year-over-year increase of 13.05%. This contributed to the annual value of $79.4 million for FY2024, which is 38.74% up from last year.
- Per Aquestive Therapeutics' latest filing, its Assets Average stood at $128.6 million for Q3 2025, which was up 31.30% from $98.0 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Assets Average ranged from a high of $128.6 million in Q3 2025 and a low of $54.1 million during Q3 2022.
- In the last 3 years, Aquestive Therapeutics' Assets Average had a median value of $98.0 million in 2025 and averaged $90.9 million.
- As far as peak fluctuations go, Aquestive Therapeutics' Assets Average skyrocketed by 108.94% in 2024, and later fell by 20.72% in 2025.
- Aquestive Therapeutics' Assets Average (Quarterly) stood at $63.6 million in 2021, then declined by 14.43% to $54.5 million in 2022, then increased by 7.30% to $58.4 million in 2023, then spiked by 80.88% to $105.7 million in 2024, then grew by 13.05% to $128.6 million in 2025.
- Its Assets Average stands at $128.6 million for Q3 2025, versus $98.0 million for Q2 2025 and $101.8 million for Q1 2025.